Selection of resistant fungi in liver transplant recipients during use of new anti-fungal agents

被引：0
|
作者：
Tan, Ban Hock [1 ]
Tan, Chee Kiat [1 ]
机构：
[1] Singapore Gen Hosp, Liver Transplant Serv, Singapore 0316, Singapore
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2008年 / 12卷
关键词：
D O I：
10.1016/S1201-9712(08)60024-7
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
22
引用
收藏
页码：S10 / S10
页数：1
相关论文
共 47 条
  • [21] MODIFICATIONS OF HORMONAL PATTERN DURING LATE PREGNANCY IN RATS TREATED WITH IMIDAZOLE ANTI-FUNGAL AGENTS - PRELIMINARY-RESULTS
    PERRAUD, J
    STADLER, J
    LATRILLE, F
    SUTTER, BCJ
    TERATOLOGY, 1985, 32 (02) : A30 - A31
  • [22] Adoptive transfer of Aspergillus-specific T cells as a novel anti-fungal therapy for hematopoietic stem cell transplant recipients: Progress and challenges
    Papadopoulou, Anastasia
    Kaloyannidis, Panayotis
    Yannaki, Evangelia
    Cruz, Conrad Russell
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 98 : 62 - 72
  • [23] DRUG-DRUG INTERACTION BETWEEN TACROLIMUS AND AZOLE ANTI-FUNGAL AGENTS, ITRACONAZOLE AND VORICONAZOLE, IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS
    Udagawa, R.
    Koido, K.
    Watabe, D.
    Yokote, N.
    Kim, S. -W
    Mori, S-, I
    Tanosaki, R.
    Heike, K.
    Fukuda, T.
    Yamamoto, H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S352 - S352
  • [24] Atypical Clinical Presentation of a Newer Generation Anti-Fungal Drug-Resistant Fusarium Infection After a Modified Multi-Visceral Transplant
    Kandeel, Ahmed
    Abu-Elmagd, Kareem
    Spinner, Michael
    Khanna, Ajai
    Hashimoto, Koji
    Fujiki, Masato
    Parsi, Mansiur
    Bennett, Ana
    El-Gazzaz, Galal
    Abd-Elaal, Ahmed
    ANNALS OF TRANSPLANTATION, 2015, 20 : 512 - 518
  • [25] The Use of Anti Hepatitis Core Liver Gtafts: De Novo Hepatitis B Recurrence in Cadaveric Liver Transplant Recipients
    Al-Sebayel, Mohammed
    AbaAlKhail, Faisal
    Hegab, Bassem
    Khalaf, Hatem
    Al-Bahili, Hamad
    Al-Hamoudi, W.
    Kamel, Y.
    Mohamed, H.
    Allam, N.
    El-Seisy, H.
    Al Masri, N.
    Al-Sofayan, M.
    Saleh, M.
    LIVER TRANSPLANTATION, 2011, 17 (06) : S292 - S293
  • [26] RELAPSE OF ALCOHOL USE IN LIVER TRANSPLANT RECIPIENTS BEFORE AND DURING THE COVID-19 PANDEMIC
    Alj, Abla
    Ruiz, Isaac
    Castel, Helene
    Bourgeois, Alexandre
    Huard, Genevieve
    Bissonnette, Julien
    Vincent, Catherine
    Bilodeau, Marc
    Hercun, Julian
    HEPATOLOGY, 2024, 80 : S1012 - S1013
  • [27] Pediatric liver transplant recipients experience similar outcomes regardless of induction agents or steroid use in immunosuppressive regimens
    Ortiz, A. Chiodo
    Al Fadaly, M.
    Kovacs, V.
    Cogua, L.
    Tupper, C.
    Naik, A.
    Faddoul, G.
    Ford, D.
    Li, M. -H.
    Koizumi, N.
    Ortiz, J.
    Erabti, S.
    LIVER TRANSPLANTATION, 2024, 30 : 92 - 92
  • [28] The use of anti-interleukin-1 agents and tumor necrosis factor-alpha inhibitors in renal transplant recipients
    Yazisiz, Veli
    Yilmaz, Vural Taner
    Ucar, Ismail
    Dandin, Ozgur
    Aslan, Bengisu
    Erbasan, Funda
    Kocak, Huseyin
    Terzioglu, Mustafa Ender
    ARCHIVES OF RHEUMATOLOGY, 2021, 36 (03) : 366 - 374
  • [29] Use of direct antiviral agents in liver transplant recipients with hepatitis C virus in Korea: 2-center experience
    Kim, Jong Man
    Lee, Kwang-Woong
    Sinn, Dong-Hyun
    Choi, Gyu-Seong
    Yi, Nam-Joon
    Kwon, Choon Hyuck David
    Suh, Kyung-Suk
    Joh, Jae-Won
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2018, 95 (03) : 147 - 151
  • [30] Use of lidocaine metabolism to test liver function during the long-term follow-up of liver transplant recipients
    Conti, F
    Dousset, B
    Cherruau, B
    Guérin, C
    Soubrane, O
    Houssin, D
    Calmus, Y
    CLINICAL TRANSPLANTATION, 2004, 18 (03) : 235 - 241
12345